• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Ex-Goldman banker convicted of bribery, money laundering conspiracy charges in 1MDB case By Reuters

April 8, 2022 admin 0

2/2 © Reuters. FILE PHOTO: Ex-Goldman Sachs banker Roger Ng and his lawyer Marc Agnifilo leave the federal court in New York, U.S., May 6, 2019. REUTERS/Jeenah Moon/ 2/2 By Luc Cohen and Jody Godoy […]

Stock News

Warner Bros Discovery’s Zaslav takes over as streaming bubble bursts By Reuters

April 8, 2022 admin 0

© Reuters. FILE PHOTO: President and CEO of Discovery David Zaslav speaks during the Discovery portion of the Television Critics Association (TCA) Summer Press Tour in Beverly Hills, California, U.S., July 25, 2019. REUTERS/Danny Moloshok […]

Stock News

Virtus Investment Partners Tumbles After Morgan Stanley Double Downgraded By Investing.com

April 8, 2022 admin 0

By Sam Boughedda Investing.com — Shares of Virtus Investment Partners Inc (NASDAQ:) tumbled 5% on Friday after Morgan Stanley downgraded the stock to underweight from overweight, slashing the price target to $240 from $393. Analyst Michael […]

Posts navigation

« 1 … 23,120 23,121 23,122 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • DAX 30 Brushes Off Retail Figures as Bullish Sentiment Returns
    February 1, 2021 0
  • Biden administration launches $6 billion nuclear power credit program By Reuters
    April 20, 2022 0
  • Xenia Hotels & Resorts Inc.’s (XHR) CEO Marcel Verbaas on Q2 2022 Results – Earnings Call Transcript
    August 5, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.